Search | WHO COVID-19 Research Database

Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report.

Ramírez-Guerrero, Gonzalo; Torres Cifuentes, Vicente; Baghetti Hernández, Romyna; Villagrán Cortés, Francisco; Rojas Doll, Simón; Oliva Alarcón, Rocio; Lucero Córdova, Cristian; Flores Fernandez, Pablo; Garay Coloma, Osvaldo.

Blood Purif ; 50(4-5): 575-577, 2021.

Article in English | MEDLINE | ID: covidwho-953495

ABSTRACT

We present the case of a patient who suffered from acute respiratory distress syndrome caused by pneumonia associated with COVID-19 and cytokine release syndrome. This patient received a high-volume hemofiltration plus adsorption, solving the hemodynamic deterioration, pulmonary infiltrates, and gas exchange. Our clinical case proposes that the extracorporeal therapies can have a role in the management of severe COVID-19.

Subject(s)

COVID-19/therapy , Critical Illness/therapy , Cytokine Release Syndrome/prevention & control , Hemofiltration , Hemoperfusion , SARS-CoV-2 , Acute Kidney Injury/etiology , Adrenal Cortex Hormones/therapeutic use , Antiviral Agents/therapeutic use , COVID-19/complications , COVID-19/diagnostic imaging , Combined Modality Therapy , Cytokine Release Syndrome/etiology , Cytokines/blood , Disease Progression , Drug Therapy, Combination , Hemoperfusion/methods , Humans , Hyperkalemia/etiology , Male , Middle Aged , Respiration, Artificial , Respiratory Distress Syndrome/diagnostic imaging , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/therapy , Vasoconstrictor Agents/therapeutic use , COVID-19 Drug Treatment

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL